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Abstract
Purpose—To assess whether radiation oncologists and surgeons differ in their attitudes 
regarding the local management of breast cancer, and to examine coordination of care between 
these specialists.
Methods and Materials—We surveyed attending surgeons and radiation oncologists who 
treated a population-based sample of patients diagnosed with breast cancer in metropolitan Detroit 
and Los Angeles. We identified 419 surgeons, of whom 318 (76%) responded, and 160 radiation 
oncologists, of whom 117 (73%) responded. We assessed demographic, professional, and practice 
characteristics; challenges to coordinated care; and attitudes toward management in three 
scenarios.
Results—92.1% of surgeons and 94.8% of radiation oncologists indicated access to a 
multidisciplinary tumor board. Nevertheless, the most commonly identified challenge to radiation 
oncologists, cited by 27.9%, was failure of other providers to include them in the treatment 
decision process early enough. Nearly half the surgeons (49.7%) stated that few or almost none of 
the breast cancer patients they saw in the past 12 months had consulted with a radiation oncologist 
before undergoing definitive surgery. Surgeons and radiation oncologists differed in their 
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recommendations in management scenarios. Radiation oncologists were more likely to favor 
radiation than were surgeons for a patient with 3/20 lymph nodes undergoing mastectomy (p = 
0.03); surgeons were more likely to favor more widely clear margins after breast conservation than 
were radiation oncologists (p = 0.001).
Conclusions—Despite the widespread availability of tumor boards, a substantial minority of 
radiation oncologists indicated other providers failed to include them in the breast cancer 
treatment decision-making process early enough. Earlier inclusion of radiation oncologists may 
influence patient decisions, and interventions to facilitate this should be considered.
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Introduction
Cancer management in the modern era commonly involves the use of multiple treatment 
modalities by providers from different specialties. Providers from different oncologic 
disciplines may have different perspectives and interpretations of the increasingly complex 
evidence base. The manner by which various specialists communicate and become involved 
in patient care may, therefore, affect patient decisions and the quality of care ultimately 
received. Consequently, interest has grown in assessing and improving the coordination and 
organization of cancer care delivery (1).
In breast cancer care, multidisciplinary involvement may be particularly important (2). As 
Keating and colleagues note, “Because many women defer to their physicians when making 
decisions about breast cancer treatment, the attitudes and beliefs of providers with whom 
they discuss surgical options may influence treatments. Such attitudes and beliefs may differ 
by physician specialty” (3). Breast cancer patients face many decisions regarding 
approaches to obtain local control of breast cancer, including extent of the primary breast 
surgery, management of the axilla, and whether to receive adjuvant radiotherapy. It is 
possible that radiation oncologists and surgeons may differ in their attitudes regarding some 
of these issues.
Patients with newly diagnosed breast cancer routinely see surgeons, but the frequency and 
timing of consultation with radiation oncologists has not been well characterized. Therefore, 
this study seeks to answer several questions. First, when do radiation oncologists become 
involved in the care of patients with newly diagnosed breast cancer? Second, do radiation 
oncologists feel that they are involved in the care of the breast cancer patient at the 
appropriate time in the decision-making process? Third, are certain provider or practice 
characteristics associated with more coordinated multidisciplinary care? And finally, do 
surgeons and radiation oncologists have different opinions regarding optimal management in 
certain common breast cancer scenarios?
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We performed a survey of attending surgeons and radiation oncologists who treated a large 
population-based sample of patients diagnosed with breast cancer, July 2005 through 
February 2007, in the metropolitan areas of Detroit and Los Angeles.
Details of the patient study have been published elsewhere (4–6). In brief, we enrolled 
women 20 to 79 years old who were reported to the Surveillance, Epidemiology, and End 
Results (SEER) registries of metropolitan Los Angeles and Detroit as having been 
diagnosed with breast cancer between June 2005 and February 2007. We excluded patients 
with Stage 4 breast cancer, those who died before the survey, those who could not complete 
a questionnaire in English or Spanish, and Asian women in Los Angeles (because of 
enrollment in other studies). Latinas (in Los Angeles) and African-Americans (in both Los 
Angeles and Detroit) were oversampled, and the eligible patient population included 
approximately 70% of the Latina and African-American patients and approximately 30% of 
non-Latina white patients diagnosed in these two metropolitan areas during the study period. 
A modified Dillman survey method was used to encourage survey response (7). Patients 
completed a survey approximately 9 months after diagnosis (96.5% by mail and 3.5% by 
phone), and this information was merged to SEER clinical data. The response rate was 
73.1% (n = 2,290). The study protocol was approved by the Institutional Review Boards of 
the University of Michigan, University of Southern California, and Wayne State University.
Using information from the patient surveys and from pathology records obtained by SEER, 
an attending surgeon was identified for 98.9% of the patient sample. Of the 1,537 patients 
who received radiotherapy, 62.3% also identified their attending radiation oncologists. 
These physicians were mailed a packet containing a letter of introduction, a survey, and a 
$40 subject fee approximately 14 months after the start of the patient survey. We again used 
a modified version of the Dillman method to optimize response (7). We identified 419 
surgeons, of whom 318 returned completed questionnaires (response rate 76%). We 
identified 160 radiation oncologists, of whom 117 returned completed questionnaires 
(response rate 73%).
Measures
The physician survey measures were developed on the basis of the literature, our prior 
research, and a conceptual model. The surgeon survey included measures of physicians' 
professional and personal characteristics (years in practice and sex); practice characteristics, 
such as the level of specialization (percent of total practice devoted to breast cancer); 
teaching status (presence of residents in the practice); and patient socioeconomic status 
(percent of patients covered by Medicaid). The surgeon survey also included items assessing 
the proportion of patients with newly diagnosed breast cancer for whom the surgeon 
discussed the treatment plan with a radiation oncologist before treatment and the proportion 
who consulted with a radiation oncologist before definitive surgery. Surgeons were also 
asked how large a problem it was to arrange to discuss the treatment plan at a tumor board 
before surgery and arranging to discuss the treatment with a radiation oncologist before the 
definitive surgery.
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The radiation oncologist survey included parallel measures of provider demographics and 
practice characteristics and context. It asked in what proportion of breast cancer patients was 
the case discussed with the surgeon before the definitive surgery, in what proportion was the 
case discussed with a medical oncologist or plastic surgeon before radiotherapy was 
initiated, and what proportion were seen in consultation before definitive surgery. Radiation 
oncologists were also asked how large a problem it was arranging to discuss the treatment 
plan at a tumor board before the final treatment decisions, arranging to discuss the treatment 
plan with a medical oncologist or plastic surgeon, arranging to discuss the treatment plan 
with the surgeon after the definitive surgery, and other providers not including the radiation 
oncologist in the patient's treatment decision process early enough.
Both surgeons and radiation oncologists were also asked to consider two patient scenarios, 
one involving a patient who elected mastectomy and the other involving a patient who 
elected breast conservation. The first scenario was used to contrast specialists' attitudes 
regarding postmastectomy radiotherapy. The second scenario was used to contrast 
specialists' attitudes toward surgical margins after breast-conserving surgery and regarding 
the need for axillary node dissection in the face of a sentinel lymph node micrometastasis.
Analysis
We first described characteristics of the surgeon and radiation oncologist study samples. 
Next, we described the distribution of responses to the items assessing radiation oncologist 
participation in patient treatment. We constructed a scale assessing challenges to 
multidisciplinary involvement by the radiation oncologist by taking the mean of responses to 
five items asking radiation oncologists how large a problem it was “arranging to discuss 
your patient's treatment plan at a tumor board prior to the final treatment decisions,” “other 
providers not including you in the patient's treatment decision process early enough,” 
“arranging to discuss the treatment plan with the surgeon after the definitive surgery,” 
“arranging to discuss the treatment plan with a medical oncologist,” and “arranging to 
discuss the treatment plan with a plastic surgeon.” Scores on this scale could range from 1 to 
5 (where 1 was anchored at “no problem,” 3 at “somewhat of a problem,” and 5 at “a big 
problem”) and actually ranged from 1 to 3.8. Cronbach's alpha was 0.75, indicating high 
internal consistency in this scale (8). We then built a multivariate model that regressed this 
scale on physician demographic and practice characteristics. Specifically, the independent 
variables examined were radiation oncologist years in practice (0–10, 11–25, 26 or more), 
radiation oncologist sex (male or female), radiation oncology practice teaching status (yes or 
no), percent of breast cancer patients in the radiation oncologist's personal practice (1–20%, 
21–35%, 36% or more), and percent of the radiation oncologist's patients with Medicaid 
insurance (15% or less vs. more than 15%). Finally, we described the distribution of 
responses to the scenarios and examined associations between provider specialty and 
response with chi-squared testing.
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Table 1 describes the demographic and practice characteristics of the responding physicians. 
Nearly one-fifth of the surgeons (17.5%) and one-third of the radiation oncologists (30.1%) 
were female. Almost half of each group (48.1% of surgeons and 41.9% of radiation 
oncologists) were part of teaching programs. Most radiation oncologists (76.5%) devoted 
between 15% and 49% of their total practice to breast cancer, and another 14.8% devoted 
50% or more, but nearly half of the surgeons (46.1%) devoted less than 15% of their total 
practice to breast cancer. Almost all surgeons (92.1%) indicated access to a meeting (e.g., a 
tumor board) where different specialists discussed the plan for cancer patients before final 
treatment decisions, and among these, 64.7% indicated that these meetings occurred weekly, 
18.0% twice a month, and 17.0% once a month. Similarly, almost all radiation oncologists 
(94.8%) indicated access to a meeting (e.g., a tumor board) where different specialists 
discussed the plan for cancer patients before final treatment decisions, and among these, 
77.5% indicated that these meetings occurred weekly, 14.4% twice a month, and 8.1% once 
a month.
Table 2 details the frequency of up-front radiation oncology consultations and discussions 
between radiation oncologists and other providers. Nearly half of the responding surgeons 
(49.7%) stated that few or almost none of the breast cancer patients they saw in the past 12 
months had consulted with a radiation oncologist before undergoing definitive surgery. Only 
a quarter of the surgeons (25.1%) reported discussing two thirds or more of their breast 
cancer patients' cases with a radiation oncologist before definitive surgery. Similarly, nearly 
half of the radiation oncologists (49.6%) also reported that few or almost none of the breast 
cancer patients they treated had consulted with them before definitive surgery, and about a 
quarter (26.3%) reported discussing two thirds or more of their breast cancer cases with the 
surgeon before definitive surgery. Only 39.1% of surgeons and 37.9% of radiation 
oncologists indicated that their practice participated regularly in same-day appointments for 
new patients with breast cancer to meet with different clinician specialists before definitive 
surgery. Over half of the responding radiation oncologists (57.0%) reported discussing 
treatment plans with a medical oncologist before commencing radiotherapy in two thirds or 
more of cases.
Table 3 presents responses regarding challenges faced by the responding providers. The 
most commonly identified challenge to radiation oncologists, cited by 27.9% of respondents, 
was failure of other providers to include them in the treatment decision process early 
enough. Other challenges reported by at least one fifth of respondents included arranging to 
discuss patients' treatment plans with a plastic surgeon (21.9%),arranging to have 
mammogram images reviewed by a radiologist (21.2%), and arranging to have pathology 
slides reviewed by a pathologist (25.0%). In addition, 19.3% of respondents reported 
challenges with arranging for patients to meet with practitioners such as social workers or 
counselors.
The mean rating for challenges to multidisciplinary involvement was 1.7, and the scale 
ranged from 1 to 3.8. In a multivariate analysis examining the relationship between radiation 
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oncologist age, radiation oncologist sex, radiation oncology practice teaching status, percent 
of Medicaid patients in the radiation oncologist's practice, and percent of breast cancer 
patients in the radiation oncologist's practice and challenges to multidisciplinary 
involvement, we found no significant associations.
Surgeon and radiation oncologist attitudes
Table 4 summarizes the attitudes of surgeons vs. radiation oncologists in two scenarios, one 
about the role of postmastectomy radiation therapy, and another about margin status and the 
need for axillary dissection in the setting of breast conservation. Details of the scenarios are 
presented in the table itself. In the scenario asking about postmastectomy radiotherapy, 
radiation oncologists were more likely to favor the use of radiotherapy than were surgeons 
(p = 0.03). In the scenario asking about margin width in the setting of breast conservation, 
radiation oncologists were more likely to accept less widely clear surgical margins than were 
surgeons (p = 0.001). After a positive sentinel node biopsy result, similar proportions of 
surgeons (79.8%) and radiation oncologists (82.6%) favored additional surgery, but 
surgeons were more likely to strongly recommend axillary node dissection (42.0% vs. 
33.0%, p = 0.04).
Discussion
We examined perspectives about the care of patients with breast cancer by surveying 
radiation oncologists and surgeons responsible for locoregional management of breast 
cancer in a population-based sample of patients from two metropolitan areas. We found that 
radiation oncologists were not involved in breast cancer treatment decision making before 
definitive surgery in a substantial proportion of cases. Nearly half of both radiation 
oncologists and surgeons reported that collaborative treatment decision making before 
surgery occurred for few or none of their patients. Additionally, a substantial minority of 
radiation oncologists reported barriers to collaborative treatment planning and access to key 
clinical information.
We also found differences of opinion when radiation oncologists and surgeons considered 
several common scenarios. Radiation oncologists were more likely to advocate for 
postmastectomy radiation therapy for a patient with N1 disease, and surgeons were more 
likely to require wider margins of resection for breast-conserving surgery. This is consistent 
with previous studies that have shown that specialists tend to favor the treatments they 
themselves deliver (9). The finding of systematic differences between radiation oncologists 
and surgeons in their attitudes toward locoregional management approaches suggests that 
the observed relative lack of early participation of radiation oncologists may be important 
for some patient groups, particularly those who are undecided about their choice of local 
therapy or those who have concerns about the side effects of radiation therapy.
Few previous studies have assessed the role of preoperative multidisciplinary consultation 
with radiation oncologists. In a retrospective cohort study of 1,188 women diagnosed with 
early breast cancer in Washington state in 1994 to 1995, 29% of patients were found to have 
consulted with a radiation oncologist before surgery (10). Among patients who received 
either breast-conserving surgery with radiotherapy and those who received mastectomy, 
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those who had a preoperative consultation with a radiation oncologist had odds of receiving 
breast conservation that were 6.7 times (p < 0.001) greater than those who did not. Although 
the authors acknowledged that women who have already chosen breast conservation may be 
encouraged to see a radiation oncologist before undergoing surgery, they also raised the 
possibility that preoperative radiation oncology consultations might affect patients' decision-
making processes.
In the modern era, the mechanism by which early involvement by radiation oncologists 
might improve the decision process is likely to be more subtle than in earlier studies 
conducted when breast conservation was less well established. Although we have clearly 
documented here that preoperative consultation with radiation oncologists was uncommon 
in this population, we have demonstrated in our previous work that these patients received 
recommendations from their surgeons regarding whether to pursue breast conservation or 
mastectomy that seemed to be generally appropriate (11). Of the 13.4% of patients who 
underwent mastectomy following the recommendation of a surgeon, most reported having 
contraindications to breast conservation, and those who sought second opinions were very 
likely to receive the same recommendation. However, we also found that 8.8% of patients 
underwent mastectomy based on a patient-directed decision; at least some of these patients 
might have been influenced by preoperative involvement by a radiation oncologist. We have 
also demonstrated that the desire to avoid radiation is strongly correlated with the choice of 
mastectomy (12, 13), and it is possible that an improved understanding of the risks and 
benefits of radiotherapy obtained through a preoperative radiation oncology consultation 
could influence decision making for some of these patients. Moreover, increased awareness 
of the role of postmastectomy radiation therapy that might be obtained in a preoperative 
consultation might have important consequences for those patients, who, had they known 
that they would likely receive radiotherapy regardless of surgical procedure, might have 
elected breast conservation rather than mastectomy. Early consultation with a radiation 
oncologist might also alter the number of patients undergoing mastectomy after attempting 
breast conservation. This occurred in 8.8% of patients in our previous study. Although 
tumor at an inked margin is regarded as unacceptable, there is no consensus on the need for 
more widely clear lumpectomy margins. Thus, attitudes regarding the adequacy of the 
surgical margin after lumpectomy are clearly an important issue (14). Our finding that 
radiation oncologists are less conservative than surgeons with regard to acceptable margin 
width could mean that earlier involvement of radiation oncologists in decision making might 
reduce re-excision rates after breast-conserving surgery (and possibly even mastectomy 
rates).
We recognize that multidisciplinary involvement in decision making may take place in 
forms other than direct preoperative consultation with a radiation oncologist, including 
multidisciplinary tumor board discussions of cases (15). The vast majority of respondents in 
this study reported access to tumor board meetings at which they could discuss cases with 
providers from different specialties. These sorts of conferences may indeed have utility (16), 
although multi-disciplinary discussions do not necessarily improve the overall quality of 
decision making (17–19). Still, it is concerning that despite this widespread access to 
multidisciplinary tumor boards, a substantial minority of the radiation oncologists 
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responding to this survey perceived as problematic the failure to include them early enough 
in the decision-making process.
This study has several strengths, including its population-based strategy to identify surgeons 
and medical oncologists treating breast cancer in the two communities considered and the 
high survey response rates. It also has certain weaknesses. First, the study was based in two 
large metropolitan areas, and its findings cannot be extrapolated to more rural settings. 
However, if there are challenges to multidisciplinary care in densely populated urban 
settings, it is likely that they also exist in rural settings, where access to radiation oncologists 
may be more difficult. The fact that we over-sampled minority patients may also limit the 
generalizability of our findings if our respondents were more likely than other providers to 
practice in underprivileged settings. There may also be biases related to the fact that treating 
radiation oncologists were not identified by all patients. Finally, the study relies upon 
physician reports of challenges, which may not correlate with patient experiences. 
Nevertheless, we believe there is substantial value in assessing the attitudes of providers, 
inasmuch as many of the potential challenges we examined would not have been apparent to 
patients and cannot easily be measured in other ways.
Ultimately, the findings of this study serve to highlight a potential area for quality 
improvement in breast cancer care. Despite the widespread availability of tumor boards for 
case discussion, a substantial minority of radiation oncologists indicated a problem with 
other providers failing to include them in the decision-making process early enough. 
Increased awareness of the systematic attitudinal differences between surgeons and radiation 
oncologists demonstrated in this study may help motivate surgeons to consult with their 
radiation oncology colleagues earlier, in particular by referring patients who are undecided 
about whether to pursue mastectomy or breast conservation, those who express concerns 
about radiotherapy, and those with larger tumors or evidence of nodal involvement at high 
risk for needing post-mastectomy radiotherapy for preoperative consultation with a radiation 
oncologist before undergoing surgery. Measures to increase the availability of same-day 
multidisciplinary clinics for breast cancer patients (20) may allow for improved participation 
of radiation oncologists in these patients' complex treatment decision-making process. In 
addition, the attitudinal differences between surgeons and radiation oncologists regarding 
margin width, the use of axillary dissection, and the need for postmastectomy radiotherapy 
suggest a role for the development of institutional guidelines in these areas or the adoption 
of national guidelines to avoid provider-based variations in care. Ultimately, if such efforts 
to increase multidisciplinary involvement before surgery are successful, patients may benefit 
from exposure to a variety of viewpoints before proceeding with definitive local therapy 
decisions, making their decision-making process more fully informed and potentially more 
in accord with their underlying preferences.
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Table 1
Respondent characteristics
Surgeons (n = 318) Radiation oncologists (n = 117)
Mean years in practice 18.5 18.4
Sex
 M 259 (82.5%) 79 (69.9%)
 F 55 (17.5%) 34 (30.1%)
Race
 White 199 (62.5%) 61 (52.1%)
 Black 15 (5.0%) 4 (3.4%)
 Asian 66 (20.8%) 37 (31.6%)
 Hispanic 24 (7.6%) 3 (2.6%)
 Other/missing 13 (4.1%) 12 (10.3%)
Teaching practice 153 (48.1%) 49 (41.9%)
Weekly work hours in patient care
 ≤40 hours 78 (25%) 64 (55%)
 41–60 hours 130 (41%) 47 (40%)
 >60 hours 108 (34%) 6 (5%)
% of practice devoted to breast cancer
 ≥50% 52 (16.5%) 17 (14.8%)
 15–49% 119 (37.7%) 88 (76.5%)
 <15% 144 (45.7%) 10 (8.7%)
% of breast cancer patients seen for second opinions
 >25% 13 (4.1%) 0
 10–25% 58 (18.4%) 14 (12.1%)
 <10% 244 (77.5%) 102 (87.9%)
Access to tumor board 292 (92.1%) 110 (94.8%)
Same-day multidisciplinary clinics 124 (39.1%) 44 (37.9%)
% of patients with Medicaid
 <5% 73 (25.8%) 14 (14.0%)
 5–15% 124 (43.8%) 50 (50.0%)
 >15% 86 (30.4%) 36 (36.0%)
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Table 2




Few or almost 
none 1/3 to 1/2 2/3 or more
Surgeon responses
 Share of patients for whom surgeon discussed plan with radiation oncologist before 
definitive surgery
43.5 31.4 25.1
 Share of patients who consulted with a radiation oncologist before definitive surgery 49.7 31.3 19.0
Radiation oncologist responses
 Share of patients seen in consultation before definitive surgery 49.6 36.5 13.9
 Share of patients for whom treatment plan was discussed with surgeon before definitive 
surgery
39.5 34.2 26.3
 Share of patients for whom radiation oncologist discussed treatment plan with medical 
oncologist before initiating radiotherapy
9.7 33.3 57.0
 Share of patients for whom radiation oncologist discussed treatment plan with plastic 
surgeon before initiating radiotherapy
78.8 16.8 4.4
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Table 3
Distribution of physician responses to items related to challenges to multidisciplinary 
involvement by radiation oncologist
Thinking about your patients in the past 12 months with newly diagnosed breast cancer, how big of a problem 
was.…
% indicating 
somewhat of a 
problem or more
Surgeon responses
 Arranging to discuss the treatment plan at a tumor board before the definitive surgery 12.5
 Arranging to discuss the treatment plan with a radiation oncologist before the definitive surgery 6.0
Radiation oncologist responses
 Other providers not including you in the patient's decision process at an early enough point 27.9
 Getting pathology specimens that were collected by another institution reviewed by your pathologist 25.0
 Arranging to discuss the treatment plan with a plastic surgeon 21.9
 Getting mammogram images that were taken at another institution reviewed by your radiologist 21.2
 Arranging for your patients to meet with practitioners such as a social worker or counselor 19.3
 Getting mammography reports for your first consultation 14.8
 Arranging to discuss your patient's treatment plan at a tumor board before the final treatment decisions 13.9
 Arranging to discuss the treatment plan with the surgeon after the definitive surgery 8.8
 Arranging to discuss the treatment plan with a medical oncologist 6.1
 Getting pathology reports for your first consultation 3.5
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